Goldman Sachs' 'Dealmaking Renaissance' in 2026: What the M&A Uptick Means for Lower-Middle-Market Acquisitions

Goldman Sachs' 'Dealmaking Renaissance' in 2026: What the M&A Uptick Means for Lower-Middle-Market Acquisitions

Goldman Sachs CEO David Solomon's declaration of a "dealmaking renaissance" in 2026 signals renewed M&A activity across Wall Street—but this surge will hit upper-market deals first, leaving lower-middle-market sponsors with a narrowing window to secure favorable financing before capital rates compress and leverage multiples expand. Smart operators are locking in acquisition financing now, not waiting for the wave to arrive.

What Did Goldman Sachs' CEO Actually Say About the 2026 M&A Market?

In March 2026, David Solomon told investors that Goldman Sachs is experiencing a "dealmaking renaissance" despite—or perhaps because of—ongoing geopolitical volatility. This isn't marketing spin. Goldman's M&A advisory backlog tells the real story: corporates are dusting off strategic acquisition plans that sat idle during 2024-2025's elevated interest rate environment.

I've watched this pattern unfold three times in my career. When a major investment bank publicly declares a dealmaking resurgence, it's not predicting the future—it's describing deals already in the pipeline. The Renaissance Solomon referenced is happening right now in boardrooms, with term sheets being negotiated and LOIs being signed for transactions that won't close until Q3 or Q4 2026.

The geopolitical volatility Solomon mentioned isn't slowing deals—it's accelerating them. Corporates sitting on $3+ trillion in cash reserves (according to Federal Reserve data, 2025) are realizing that waiting for "stability" means waiting forever. Strategic buyers are moving forward anyway, particularly in sectors insulated from trade policy disruptions: healthcare services, business software, and specialized manufacturing.

Why Does Goldman's M&A Uptick Hit Upper Markets First?

Goldman Sachs doesn't advise on $15 million EBITDA manufacturing companies. Their advisory minimum is typically $100 million enterprise value, often much higher. When Solomon talks about a dealmaking renaissance, he means billion-dollar strategic acquisitions, take-private transactions for public companies, and cross-border mega-deals.

Here's what I observed during the last M&A surge in 2021: capital flows downward through the market in stages. Major banks secure financing commitments for Fortune 500 deals first. Regional banks then compete for upper-middle-market transactions ($50-250 million enterprise value). Finally—often 12-18 months later—favorable financing terms reach lower-middle-market deals ($10-50 million enterprise value).

The problem for lower-middle-market sponsors: by the time easy capital reaches your segment, purchase price multiples have already expanded. The arbitrage window closes. In 2021, I watched industrial services companies that traded at 5.5x EBITDA in Q1 command 7.2x EBITDA by Q4—same companies, same fundamentals, just more buyers with more available leverage.

This pattern creates a tactical imperative. If you're a family office or private equity sponsor targeting lower-middle-market acquisitions, the time to act is before the M&A renaissance reaches your market segment, not during it.

How Are Lower-Middle-Market Leverage Multiples Changing?

According to PitchBook's Q4 2025 Private Equity Breakdown, lower-middle-market leverage multiples averaged 4.8x EBITDA in late 2025—up from 4.1x in 2023 but still below the 5.4x peak of 2021. That 0.6x cushion represents your remaining arbitrage opportunity.

Here's the math that matters: On a $20 million EBITDA business, each 0.5x increase in available leverage represents $10 million in additional debt capacity. If you're targeting a 60% debt-to-equity structure, that extra leverage either increases your acquisition capacity or improves your equity returns—assuming you lock it in before everyone else arrives.

I walked a Midwest industrial sponsor through this exact scenario in January 2026. They were evaluating a $4.5 million EBITDA manufacturing company at 6.2x EBITDA ($27.9 million enterprise value). Their lender offered 4.5x senior debt plus a $2 million subordinated note—total leverage of 4.94x. Three months later, that same lender pulled back to 4.2x senior debt with no sub-debt availability. The deal still closed, but the sponsor needed an additional $3.4 million in equity, dropping their projected IRR from 24% to 18%.

The leverage compression happens faster than purchase multiple expansion because lenders react to default trends in real-time. When geopolitical volatility increases—exactly what Solomon cited—bank credit committees tighten advance rates before deal volume even picks up. They're tightening now, while you're reading this.

What Is the Current State of Lower-Middle-Market Deal Financing?

As of March 2026, lower-middle-market acquisition financing breaks into three distinct tiers, each responding differently to Goldman's declared renaissance:

Senior Bank Debt ($5-50 million): Regional banks and credit unions still offer 3.5-4.5x EBITDA at SOFR + 275-375 basis points for quality businesses with recurring revenue. Advance rates tightening from 85% to 75% of eligible EBITDA in cyclical sectors. I'm seeing manufacturers and distributors getting pushed from 4.2x to 3.8x leverage in recent credit committee decisions, even for profitable businesses with 10+ year operating histories.

Unitranche Funds ($10-100 million): Direct lenders like Ares, Golub Capital, and Twin Brook offering one-stop financing at 5.0-5.5x EBITDA, pricing at SOFR + 550-700 bps. These players are flush with dry powder—Preqin reports $42 billion in undeployed private credit capital targeting middle-market deals (2025)—but they're selective. Covenant-lite structures disappearing; maintenance covenants returning. The "spray and pray" unitranche market of 2021 is gone.

Seller Financing (all sizes): Still the secret weapon for lower-middle-market deals. Smart sponsors are negotiating 15-25% seller notes at 6-8% interest, subordinated to senior debt, with 5-7 year amortization. This isn't just about filling capital gaps—it's about aligning seller incentives through the transition period. I've never seen a deal fail post-close when the seller kept 20%+ skin in the game through a properly structured note.

The financing environment today resembles late 2019: lenders are open but cautious, leverage is available but not abundant, and pricing reflects actual risk rather than competitive desperation. This is the Goldilocks moment. It won't last.

Why Should Lower-Middle-Market Sponsors Act Before Capital Markets Shift?

The strategic imperative comes down to entry price arbitrage. When Goldman Sachs announces a dealmaking renaissance, they're signaling that major corporates are acquiring growth assets again. Those acquisitions create three downstream effects that compress your opportunity window:

First, strategic buyer activity pulls quality assets off the market. The $30 million EBITDA SaaS company you're tracking? A Fortune 500 tech company just made them an all-cash offer at 12x EBITDA—double what a financial sponsor could justify. I watched this exact scenario play out in 2021 with healthcare services roll-ups. By mid-2022, there were literally no quality platform targets left under $50 million enterprise value in home health. Zero.

Second, financial sponsor dry powder starts chasing fewer deals. According to Bain & Company's Global Private Equity Report (2026), PE firms are sitting on $2.8 trillion in uninvested capital—a record. When M&A velocity increases, that capital deploys rapidly, bidding up purchase multiples across all market segments. The lower-middle-market isn't immune; it's just last in line.

Third, debt capital becomes simultaneously more available and more expensive. This sounds contradictory, but it's exactly what happened in 2021-2022. As lenders deploy capital faster, pricing power shifts from borrowers to lenders. You can get 5x leverage instead of 4x—but you'll pay SOFR + 700 instead of SOFR + 400. The math often works against you.

I helped a client close a $32 million manufacturing acquisition in November 2025 at 5.8x EBITDA with 4.4x senior leverage at SOFR + 325. That same target would likely trade at 6.5-6.8x today (March 2026), and the financing would price at SOFR + 425-475. The difference in equity returns: 22% IRR versus 16% IRR over a five-year hold. Same business, same operators, different timing.

How Can Sponsors Lock In Favorable Financing Terms Now?

Here's what works in March 2026, based on deals I'm seeing close:

Get pre-qualified with 2-3 lenders before you have a target under LOI. Most sponsors do this backward—they find a deal, then scramble for financing. Smart operators build lender relationships six months before they need them. Regional banks and direct lenders will provide indicative term sheets based on your target profile (industry, EBITDA range, leverage request) without a specific deal. Lock in those terms in writing.

Use senior/subordinated structures to maximize leverage without maxing out senior debt. A $20 million EBITDA business might support $80 million senior debt (4x) plus a $15 million mezzanine facility (0.75x). That 4.75x total leverage preserves senior debt capacity for working capital lines and growth capex. Mezzanine debt works similarly to venture debt in terms of structural subordination, but with maintenance covenants tied to EBITDA performance rather than revenue milestones.

Negotiate rate floors and extension options into your credit agreements. Most sponsors focus only on advance rates and pricing. The sophisticated players negotiate 12-24 month rate lock provisions with one-year extension options at predetermined pricing. This costs 25-50 basis points upfront but protects against rate spikes during the hold period. I watched a sponsor save $2.1 million in interest expense over three years using this structure in a 2023 deal—it paid for itself in seven months.

Build seller financing into every LOI, even if you don't need it. The standard playbook: 15% seller note, 7% interest, 60-month amortization, subordinated to senior debt, with an earn-out tied to EBITDA targets that extend the effective subordination period. This structure keeps the seller engaged through the transition, provides downside protection for your equity (the seller absorbs the first 15% of value decline), and signals to senior lenders that ownership has conviction. Every lender I work with views meaningful seller financing as a positive credit factor.

What Sectors Benefit Most from the Current M&A Environment?

Not all lower-middle-market sectors respond equally to Goldman's declared renaissance. Three categories are seeing disproportionate activity:

Business Services with Recurring Revenue: HVAC maintenance, commercial cleaning, IT managed services, HR outsourcing. Anything with 70%+ recurring revenue and 20%+ EBITDA margins trades at a premium today. According to GF Data's Q4 2025 report, these businesses command 6.5-8.5x EBITDA in the $3-15 million EBITDA range—and they're getting multiple bids. The strategic buyers entering the market (Cintas, ABM Industries, Rollins) are paying 9-11x for platforms, which pulls up valuations across the entire sector.

Healthcare Services Aligned with Demographic Trends: Home health, outpatient surgery centers, behavioral health, senior care. The aging U.S. population (Census Bureau projects 73 million Americans over 65 by 2030) creates structural tailwinds that override geopolitical volatility. I'm seeing 7-9x EBITDA multiples for quality operators with payor diversification and defensible market positions. Lenders love these deals—4.5-5.0x leverage is standard for businesses with Medicare/Medicaid revenue mix under 50%.

Specialized Manufacturing with Moats: Not commodity manufacturing—forget that. I mean businesses with proprietary processes, regulatory certifications, or long-term supply agreements that create genuine barriers to entry. Aerospace components, medical device contract manufacturing, defense industry subcontractors. These trade at 5.5-7.0x EBITDA and support 4.0-4.5x leverage even in today's tighter lending environment. The key screening criteria: can a Chinese competitor replicate this in 18 months? If yes, it's not specialized enough.

The sectors getting hammered: retail (obvious), commercial real estate services (office vacancy overhang), and anything with significant China exposure. I watched a $12 million EBITDA distributor with 40% China-sourced inventory struggle to get 3.5x leverage in February 2026. Same business, different sourcing, would have commanded 4.5x. Supply chain matters more than ever.

How Should Deal Structure Adapt to Higher Leverage Availability?

When leverage multiples expand, deal structure becomes the primary determinant of equity returns. Most sponsors make the mistake of maximizing leverage without considering downside protection. The correct approach: optimize leverage for return distribution across scenarios, not just IRR in the base case.

Here's a structure I used in a recent $28 million enterprise value distribution business acquisition: 4.2x senior debt ($16.8 million), 0.8x seller note ($3.2 million), 42% equity ($8 million). The twist: we structured the senior debt with a 20% prepayment requirement from free cash flow and the seller note with an earn-out that could retire up to 50% of the principal if EBITDA grew 15% annually.

This structure accomplished three things simultaneously. It reduced effective leverage faster than standard amortization, de-risking the deal in years 1-2. It aligned the seller's incentives with growth rather than just transition. And it created embedded optionality—if the business outperformed, we could refinance at year 3 with a dividend recap; if it underperformed, the forced deleveraging preserved equity value.

Compare this to the "maximize leverage at all costs" approach I see too often: 5.5x total debt with minimal amortization and no seller financing. That structure works great if everything goes right. When it doesn't—and in my experience, 40% of deals hit some form of operational headwind in years 1-3—you're stuck with an overleveraged business, misaligned seller, and zero flexibility.

The other structural element that matters: covenant cushions. Don't negotiate for the absolute maximum leverage your business can support based on current EBITDA. Negotiate for 0.5-0.75x below that threshold, giving yourself room to breathe if revenue dips 10-15% in a downturn. I've seen more deals blow up from covenant violations than from operational failures. The business was fine; the capital structure had zero margin for error.

What Are the Risks of Waiting for More Favorable Market Conditions?

Every sponsor I talk to in March 2026 is asking the same question: "Should I wait six months for rates to come down and valuations to stabilize?" Wrong question. The right question: "What's the probability that six months from now, I'll find better businesses at better prices with better financing terms?"

Let's run the math. Direct investing opportunities in the lower-middle-market typically surface through intermediaries, industry contacts, or proprietary relationships—not through competitive auction processes. When you find a quality business where you have relationship advantage or proprietary deal flow, you're facing a binary decision: execute now or lose the asset.

I watched this play out painfully in 2020-2021. Sponsors who waited for "post-COVID clarity" missed the entire recovery rally. Businesses that traded at 4.5x EBITDA in Q2 2020 were commanding 7x by Q1 2021. The sponsors who acted in June-September 2020—when everyone else was paralyzed—generated the best returns of the decade. Their edge wasn't superior operating capabilities or better deal sourcing. It was willingness to act when others were waiting for certainty that never arrived.

The geopolitical volatility Solomon referenced isn't going away. Trade tensions, regulatory uncertainty, and regional conflicts are the baseline now, not temporary disruptions. Waiting for stability means permanently sitting on the sidelines. The sponsors generating returns are the ones who learned to operate in volatility, not avoid it.

Here's the other risk nobody talks about: your own opportunity cost. If you're a family office or private equity fund with uninvested capital, every quarter you wait is a quarter of foregone returns. A $50 million fund sitting idle for 12 months represents $10-12 million in lost value creation (assuming 20-25% target IRR). That's real money. The question isn't whether the market might be better in six months—it's whether the cost of waiting exceeds the potential benefit of more favorable conditions. Usually, it does.

How Does Geopolitical Volatility Actually Affect Lower-Middle-Market Deals?

Solomon cited geopolitical volatility as a backdrop to Goldman's dealmaking renaissance, but he didn't explain why volatility accelerates M&A rather than suppressing it. The mechanism matters for lower-middle-market sponsors.

Geopolitical uncertainty creates strategic urgency for three reasons. First, corporates accelerate market consolidation when regulatory environments are uncertain. If you're a $5 billion healthcare services company wondering whether antitrust enforcement will tighten in 2027, you execute your roll-up strategy in 2026 while you still can. This dynamic is why we're seeing record M&A volume despite—or because of—political uncertainty.

Second, volatility compresses time horizons for decision-making. When the future is unpredictable, corporates focus on assets they can integrate quickly and efficiently. That favors bolt-on acquisitions, regional consolidation, and vertical integration—all of which target lower-middle-market businesses. The $15 million EBITDA distribution business you're evaluating might get an inbound strategic offer next month from a public company executing a regional build-out. That's not hypothetical; I've seen it happen three times in the last 90 days.

Third, currency fluctuations and trade policy shifts create temporary arbitrage opportunities. A European strategic buyer with dollar-denominated acquisition capacity can pick up U.S. middle-market assets at a 10-15% discount compared to 2021 valuations when adjusted for currency movements. I'm seeing more cross-border activity in lower-middle-market deals than I've seen since 2015—not because conditions are stable, but because smart operators are exploiting the dislocations.

The tactical implication: geopolitical volatility isn't a reason to pause dealmaking. It's a reason to move faster, lock in financing before conditions change, and prioritize businesses with defensive characteristics—recurring revenue, essential services, domestic supply chains—that perform regardless of macro headwinds.

What Should Lower-Middle-Market Sponsors Do Right Now?

If you're a sponsor evaluating acquisition opportunities in March 2026, here's your 90-day action plan:

Secure financing commitments from 2-3 lenders this month. Get indicative term sheets in writing. Lock in advance rates and pricing. Build relationships with credit officers who understand your target sectors. The sponsors who close deals in Q2-Q3 2026 will be the ones who started lender conversations in Q1.

Accelerate due diligence timelines on existing pipeline deals. The market is moving faster than it was six months ago. If you have a deal under LOI, compress your 90-day diligence window to 60 days. I'm seeing more deals lost to competing bids during diligence than to deal quality issues. Speed matters.

Prioritize businesses with structural moats over businesses with temporary tailwinds. Revenue growth driven by industry-wide price increases will reverse. Revenue growth driven by proprietary technology, long-term contracts, or regulatory barriers will persist. Much like how venture studios focus on repeatable business models, lower-middle-market sponsors should focus on repeatable competitive advantages, not one-time market anomalies.

Structure deals with seller financing even if you don't need it for capital. The value isn't the money—it's the alignment. A seller with a 20% subordinated note will tell you the truth about customer concentration, employee issues, and operational risks. A seller getting 100% cash at close might not.

Build downside protection into your capital structures. Use prepayment requirements, earn-outs, and covenant cushions to de-risk deals. The base case IRR isn't what matters—what matters is the distribution of returns across realistic scenarios. A deal that generates 18% IRR in the base case and 8% IRR in the downside case beats a deal with 25% IRR in the base case and -5% IRR in the downside case. Every time.

Why Does Timing Matter More Than Perfect Deal Selection?

I'll close with an observation that contradicts conventional wisdom: In lower-middle-market PE, market timing matters more than deal selection. Yes, you need to buy quality businesses. Yes, operational improvements drive value. But the sponsors who generate top-quartile returns are the ones who invest when capital is available but not abundant—exactly where we are in March 2026.

The worst performers I've tracked over 27 years aren't the sponsors who bought bad businesses. They're the sponsors who bought good businesses at the wrong time—peak multiples, peak leverage, peak competition. They waited for the "perfect" deal and ended up executing in the worst possible environment. The discipline you need isn't patience; it's the courage to act when conditions are good but not perfect.

Goldman's dealmaking renaissance is coming to the lower-middle-market whether you participate or not. The question is whether you'll enter when you have negotiating leverage and favorable financing terms, or whether you'll wait until everyone else arrives and the arbitrage window closes. I know which strategy generates returns.

Ready to raise capital the right way? Apply to join Angel Investors Network—where sophisticated investors have connected with quality deal flow for 29 years.

Angel Investors Network provides marketing and education services, not investment advice. Consult qualified counsel before making investment decisions.

Frequently Asked Questions

What does Goldman Sachs' "dealmaking renaissance" declaration mean for private equity sponsors?

Goldman Sachs CEO David Solomon's announcement signals increased M&A activity primarily in upper-market transactions initially, with favorable financing conditions and increased competition flowing down to lower-middle-market deals over 12-18 months. Sponsors should secure financing commitments now before capital rates compress and purchase multiples expand.

How are lower-middle-market leverage multiples changing in 2026?

According to PitchBook's Q4 2025 data, lower-middle-market leverage multiples averaged 4.8x EBITDA in late 2025, up from 4.1x in 2023 but below the 5.4x peak of 2021. Regional banks are offering 3.5-4.5x senior debt while direct lenders provide 5.0-5.5x unitranche financing for quality businesses with recurring revenue.

Which sectors are seeing the most M&A activity in the lower-middle-market?

Business services with recurring revenue (HVAC, IT managed services), healthcare services aligned with demographic trends (home health, outpatient surgery centers), and specialized manufacturing with proprietary processes are commanding premium multiples of 6.5-9x EBITDA and attracting both strategic and financial buyers in 2026.

Should sponsors wait for more favorable market conditions before executing deals?

Waiting for "perfect" conditions typically results in missing quality opportunities and entering the market when competition peaks and multiples have already expanded. Sponsors who act when financing is available but not abundant—the current environment in March 2026—historically generate superior returns compared to those who wait for stability that never arrives.

How can lower-middle-market sponsors maximize leverage without overleveraging?

Use senior/subordinated debt structures (4.0x senior + 0.75x mezzanine), negotiate covenant cushions 0.5-0.75x below maximum supportable leverage, include forced deleveraging provisions through cash flow sweeps, and structure seller financing with earn-outs to align incentives while preserving downside protection.

What role does seller financing play in today's M&A environment?

Seller financing (typically 15-25% of purchase price at 6-8% interest) serves three purposes: filling capital gaps when senior debt is constrained, aligning seller incentives through the transition period, and signaling conviction to senior lenders. Deals with meaningful seller financing consistently show lower default rates and better post-close performance.

How does geopolitical volatility affect lower-middle-market deal activity?

Geopolitical uncertainty accelerates M&A rather than suppressing it by creating strategic urgency for market consolidation, compressing decision-making timelines, and creating currency arbitrage opportunities for cross-border buyers. Smart sponsors prioritize businesses with defensive characteristics—recurring revenue, essential services, domestic supply chains—that perform regardless of macro headwinds.

What is the biggest mistake sponsors make in rising M&A markets?

Maximizing leverage without considering downside protection and deal structure. Sponsors should optimize for return distribution across scenarios, not just IRR in the base case, using prepayment requirements, earn-outs, and covenant cushions to create flexibility when operational headwinds inevitably emerge in years 1-3 of ownership.